Vimal Mehta - Sep 14, 2023 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Signature
/s/ Richard Steinhart, as Attorney in Fact for Vimal Mehta, Ph.D.
Stock symbol
BTAI
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
4
Date filed
9/18/2023, 04:47 PM
Previous filing
Jun 16, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTAI Common Stock Options Exercise +2.61K +9.67% 29.6K Sep 14, 2023 Direct F1, F2
holding BTAI Common Stock 2K Sep 14, 2023 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Restricted Stock Units Options Exercise $0 -2.61K -9.09% $0.00 26.1K Sep 14, 2023 Common Stock 2.61K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents adjustment in number of shares to correct an inadvertent error in the number of shares directly owned following the reported transaction in the Form 4 filed on May 24, 2023 and Form 4s filed thereafter.
F3 On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.